Skip to main content
. 2016 Feb 12;5(2):e002160. doi: 10.1161/JAHA.115.002160

Figure 2.

Figure 2

Kaplan–Meier event curves for the primary endpoint (cardiovascular death or heart failure hospitalization) (A), heart failure hospitalization (B), and all‐cause mortality (C) in placebo (left) and ivabradine (right) patients according to thirds of coefficient of heart rate variation (HR CV). Cox regression P values are given.